Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Peptides and Heparin industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Cipla Ltd
United Biotech (P) Limited
Troikaa Pharmaceuticals Ltd
Biological E Limited
VHB Life Sciences Limited
Biocon Limited
Sun Pharmaceutical Industries Ltd
Samarth Life Sciences Pvt Ltd
Wockhardt Ltd
Bharat Biotech
Emcure Pharmaceuticals Pvt Ltd
By Type:
Insulin
Liraglutide
Enaxaparin Sodium
Calcitonin
Exenatide
Teriparatide
Heparin Sodium
Leuprolide
By Application:
Diabetes
Infectious Diseases
Osteoporosis
Cancer
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Peptides and Heparin Market Overview 2018-2029
-
1.1 China Peptides and Heparin Industry Development Overview
-
1.2 China Peptides and Heparin Industry Development History
-
1.3 China Peptides and Heparin Industry Market Size (2018-2029)
-
1.4 China Peptides and Heparin Market Analysis by Type from Production Side
-
1.4.1 China Peptides and Heparin Production Volume, Production Value and Growth Rate of Insulin (2018-2029)
-
1.4.2 China Peptides and Heparin Production Volume, Production Value and Growth Rate of Liraglutide (2018-2029)
-
1.4.3 China Peptides and Heparin Production Volume, Production Value and Growth Rate of Enaxaparin Sodium (2018-2029)
-
1.4.4 China Peptides and Heparin Production Volume, Production Value and Growth Rate of Calcitonin (2018-2029)
-
1.4.5 China Peptides and Heparin Production Volume, Production Value and Growth Rate of Exenatide (2018-2029)
-
1.4.6 China Peptides and Heparin Production Volume, Production Value and Growth Rate of Teriparatide (2018-2029)
-
1.4.7 China Peptides and Heparin Production Volume, Production Value and Growth Rate of Heparin Sodium (2018-2029)
-
1.4.8 China Peptides and Heparin Production Volume, Production Value and Growth Rate of Leuprolide (2018-2029)
-
1.5 China Peptides and Heparin Market Analysis by Application from Consumption End
-
1.5.1 China Peptides and Heparin Sales Volume, Sales Value and Growth Rate of Diabetes (2018-2029)
-
1.5.2 China Peptides and Heparin Sales Volume, Sales Value and Growth Rate of Infectious Diseases (2018-2029)
-
1.5.3 China Peptides and Heparin Sales Volume, Sales Value and Growth Rate of Osteoporosis (2018-2029)
-
1.5.4 China Peptides and Heparin Sales Volume, Sales Value and Growth Rate of Cancer (2018-2029)
-
1.6 China Peptides and Heparin Market Analysis by Region
-
1.6.1 North China Peptides and Heparin Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Peptides and Heparin Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Peptides and Heparin Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Peptides and Heparin Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Peptides and Heparin Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Peptides and Heparin Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Peptides and Heparin Market Size and Growth Rate from 2018-2029
Chapter 2 China Peptides and Heparin Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Peptides and Heparin Market Status and Competition at home and abroad in 2023
-
2.2.2 China Peptides and Heparin Market Status and Competition Analysis in 2023
-
2.2.3 China Peptides and Heparin Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Peptides and Heparin Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Peptides and Heparin Industry Development
Chapter 3 Peptides and HeparinIndustry Chain Analysis
-
3.1 Peptides and Heparin Industry Chain
-
3.2 Peptides and Heparin Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Peptides and Heparin Market
-
3.3 Peptides and Heparin Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Peptides and Heparin Market
Chapter 4 China Peptides and Heparin Market, by Type
-
4.1 China Peptides and Heparin Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Peptides and Heparin Total Production Volume and Growth Rate from Production Side
-
4.5 China Peptides and Heparin Production Volume and Growth Rate, by Type
-
4.5.1 China Peptides and Heparin Production Volume and Growth Rate of Insulin
-
4.5.2 China Peptides and Heparin Production Volume and Growth Rate of Liraglutide
-
4.5.3 China Peptides and Heparin Production Volume and Growth Rate of Enaxaparin Sodium
-
4.5.4 China Peptides and Heparin Production Volume and Growth Rate of Calcitonin
-
4.5.5 China Peptides and Heparin Production Volume and Growth Rate of Exenatide
-
4.5.6 China Peptides and Heparin Production Volume and Growth Rate of Teriparatide
-
4.5.7 China Peptides and Heparin Production Volume and Growth Rate of Heparin Sodium
-
4.5.8 China Peptides and Heparin Production Volume and Growth Rate of Leuprolide
Chapter 5 China Peptides and Heparin Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Peptides and Heparin Total Market Size and Growth Rate from Consumption End
-
5.5 China Peptides and Heparin Market Size and Growth Rate, by Application
-
5.5.1 China Peptides and Heparin Market Size and Growth Rate of Diabetes
-
5.5.2 China Peptides and Heparin Market Size and Growth Rate of Infectious Diseases
-
5.5.3 China Peptides and Heparin Market Size and Growth Rate of Osteoporosis
-
5.5.4 China Peptides and Heparin Market Size and Growth Rate of Cancer
Chapter 6 China Peptides and Heparin Market, by Region
-
6.1 China Peptides and Heparin Production Volume and Production Value, by Region
-
6.2 China Peptides and Heparin Sales Volume and Sales Value, by Region
Chapter 7 North China Peptides and Heparin Market Analysis
-
7.1 North China Peptides and Heparin Market, by Type
-
7.2 North China Peptides and Heparin Market, by Application
Chapter 8 Central China Peptides and Heparin Market Analysis
-
8.1 Central China Peptides and Heparin Market, by Type
-
8.2 Central China Peptides and Heparin Market, by Application
Chapter 9 South China Peptides and Heparin Market Analysis
-
9.1 South China Peptides and Heparin Market, by Type
-
9.2 South China Peptides and Heparin Market, by Application
Chapter 10 East China Peptides and Heparin Market Analysis
-
10.1 East China Peptides and Heparin Market, by Type
-
10.2 East China Peptides and Heparin Market, by Application
Chapter 11 Northeast China Peptides and Heparin Market Analysis
-
11.1 Northeast China Peptides and Heparin Market, by Type
-
11.2 Northeast China Peptides and Heparin Market, by Application
Chapter 12 Southwest China Peptides and Heparin Market Analysis
-
12.1 Southwest China Peptides and Heparin Market, by Type
-
12.2 Southwest China Peptides and Heparin Market, by Application
Chapter 13 Northwest China Peptides and Heparin Market Analysis
-
13.1 Northwest China Peptides and Heparin Market, by Type
-
13.2 Northwest China Peptides and Heparin Market, by Application
Chapter 14 Company Profiles
-
14.1 Cipla Ltd
-
14.1.1 Cipla Ltd Company Profile
-
14.1.2 Cipla Ltd Peptides and Heparin Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 United Biotech (P) Limited
-
14.2.1 United Biotech (P) Limited Company Profile
-
14.2.2 United Biotech (P) Limited Peptides and Heparin Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Troikaa Pharmaceuticals Ltd
-
14.3.1 Troikaa Pharmaceuticals Ltd Company Profile
-
14.3.2 Troikaa Pharmaceuticals Ltd Peptides and Heparin Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Biological E Limited
-
14.4.1 Biological E Limited Company Profile
-
14.4.2 Biological E Limited Peptides and Heparin Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 VHB Life Sciences Limited
-
14.5.1 VHB Life Sciences Limited Company Profile
-
14.5.2 VHB Life Sciences Limited Peptides and Heparin Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Biocon Limited
-
14.6.1 Biocon Limited Company Profile
-
14.6.2 Biocon Limited Peptides and Heparin Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Sun Pharmaceutical Industries Ltd
-
14.7.1 Sun Pharmaceutical Industries Ltd Company Profile
-
14.7.2 Sun Pharmaceutical Industries Ltd Peptides and Heparin Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Samarth Life Sciences Pvt Ltd
-
14.8.1 Samarth Life Sciences Pvt Ltd Company Profile
-
14.8.2 Samarth Life Sciences Pvt Ltd Peptides and Heparin Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Wockhardt Ltd
-
14.9.1 Wockhardt Ltd Company Profile
-
14.9.2 Wockhardt Ltd Peptides and Heparin Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Bharat Biotech
-
14.10.1 Bharat Biotech Company Profile
-
14.10.2 Bharat Biotech Peptides and Heparin Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Emcure Pharmaceuticals Pvt Ltd
-
14.11.1 Emcure Pharmaceuticals Pvt Ltd Company Profile
-
14.11.2 Emcure Pharmaceuticals Pvt Ltd Peptides and Heparin Market Performance
-
14.11.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Peptides and Heparin Industry Research Conclusions
-
15.2 Peptides and Heparin Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Peptides and Heparin Industry Market Size (2018-2029)
-
Figure China Peptides and Heparin Production Volume, Production Value and Growth Rate of Insulin (2018-2029)
-
Figure China Peptides and Heparin Production Volume, Production Value and Growth Rate of Liraglutide (2018-2029)
-
Figure China Peptides and Heparin Production Volume, Production Value and Growth Rate of Enaxaparin Sodium (2018-2029)
-
Figure China Peptides and Heparin Production Volume, Production Value and Growth Rate of Calcitonin (2018-2029)
-
Figure China Peptides and Heparin Production Volume, Production Value and Growth Rate of Exenatide (2018-2029)
-
Figure China Peptides and Heparin Production Volume, Production Value and Growth Rate of Teriparatide (2018-2029)
-
Figure China Peptides and Heparin Production Volume, Production Value and Growth Rate of Heparin Sodium (2018-2029)
-
Figure China Peptides and Heparin Production Volume, Production Value and Growth Rate of Leuprolide (2018-2029)
-
Figure China Peptides and Heparin Sales Volume, Sales Value and Growth Rate of Diabetes (2018-2029)
-
Figure China Peptides and Heparin Sales Volume, Sales Value and Growth Rate of Infectious Diseases (2018-2029)
-
Figure China Peptides and Heparin Sales Volume, Sales Value and Growth Rate of Osteoporosis (2018-2029)
-
Figure China Peptides and Heparin Sales Volume, Sales Value and Growth Rate of Cancer (2018-2029)
-
Figure North China Peptides and Heparin Market Size and Growth Rate from 2018-2029
-
Figure Central China Peptides and Heparin Market Size and Growth Rate from 2018-2029
-
Figure South China Peptides and Heparin Market Size and Growth Rate from 2018-2029
-
Figure East China Peptides and Heparin Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Peptides and Heparin Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Peptides and Heparin Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Peptides and Heparin Market Size and Growth Rate from 2018-2029
-
Figure Peptides and Heparin Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Peptides and Heparin Market Share by Type in 2018
-
Figure China Peptides and Heparin Market Share by Type in 2023
-
Figure China Peptides and Heparin Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Peptides and Heparin Production Volume and Growth Rate of Insulin (2018-2023)
-
Figure China Peptides and Heparin Production Volume and Growth Rate of Liraglutide (2018-2023)
-
Figure China Peptides and Heparin Production Volume and Growth Rate of Enaxaparin Sodium (2018-2023)
-
Figure China Peptides and Heparin Production Volume and Growth Rate of Calcitonin (2018-2023)
-
Figure China Peptides and Heparin Production Volume and Growth Rate of Exenatide (2018-2023)
-
Figure China Peptides and Heparin Production Volume and Growth Rate of Teriparatide (2018-2023)
-
Figure China Peptides and Heparin Production Volume and Growth Rate of Heparin Sodium (2018-2023)
-
Figure China Peptides and Heparin Production Volume and Growth Rate of Leuprolide (2018-2023)
-
Figure China Peptides and Heparin Market Share by Application in 2018
-
Figure China Peptides and Heparin Market Share by Application in 2023
-
Figure China Peptides and Heparin Total Market Size and Growth Rate from Consumption End
-
Figure China Peptides and Heparin Market Size and Growth Rate of Diabetes (2018-2023)
-
Figure China Peptides and Heparin Market Size and Growth Rate of Infectious Diseases (2018-2023)
-
Figure China Peptides and Heparin Market Size and Growth Rate of Osteoporosis (2018-2023)
-
Figure China Peptides and Heparin Market Size and Growth Rate of Cancer (2018-2023)
-
Table China Peptides and Heparin Production Volume by Region (2018-2023)
-
Table China Peptides and Heparin Production Volume Share by Region (2018-2023)
-
Figure China Peptides and Heparin Production Volume Share by Region (2018-2023)
-
Table China Peptides and Heparin Production Value by Region (2018-2023)
-
Table China Peptides and Heparin Production Value Share by Region (2018-2023)
-
Figure China Peptides and Heparin Production Value Share by Region (2018-2023)
-
Table China Peptides and Heparin Sales Volume by Region (2018-2023)
-
Table China Peptides and Heparin Sales Volume Share by Region (2018-2023)
-
Figure China Peptides and Heparin Sales Volume Share by Region (2018-2023)
-
Table China Peptides and Heparin Sales Value by Region (2018-2023)
-
Table China Peptides and Heparin Sales Value Share by Region (2018-2023)
-
Figure China Peptides and Heparin Sales Value Share by Region (2018-2023)
-
Table North China Peptides and Heparin Production Volume by Type (2018-2023)
-
Table North China Peptides and Heparin Production Volume Share by Type (2018-2023)
-
Figure North China Peptides and Heparin Production Volume Share by Type (2018-2023)
-
Table North China Peptides and Heparin Sales Volume by Application (2018-2023)
-
Table North China Peptides and Heparin Sales Volume Share by Application (2018-2023)
-
Figure North China Peptides and Heparin Sales Volume Share by Application (2018-2023)
-
Table Central China Peptides and Heparin Production Volume by Type (2018-2023)
-
Table Central China Peptides and Heparin Production Volume Share by Type (2018-2023)
-
Figure Central China Peptides and Heparin Production Volume Share by Type (2018-2023)
-
Table Central China Peptides and Heparin Sales Volume by Application (2018-2023)
-
Table Central China Peptides and Heparin Sales Volume Share by Application (2018-2023)
-
Figure Central China Peptides and Heparin Sales Volume Share by Application (2018-2023)
-
Table South China Peptides and Heparin Production Volume by Type (2018-2023)
-
Table South China Peptides and Heparin Production Volume Share by Type (2018-2023)
-
Figure South China Peptides and Heparin Production Volume Share by Type (2018-2023)
-
Table South China Peptides and Heparin Sales Volume by Application (2018-2023)
-
Table South China Peptides and Heparin Sales Volume Share by Application (2018-2023)
-
Figure South China Peptides and Heparin Sales Volume Share by Application (2018-2023)
-
Table East China Peptides and Heparin Production Volume by Type (2018-2023)
-
Table East China Peptides and Heparin Production Volume Share by Type (2018-2023)
-
Figure East China Peptides and Heparin Production Volume Share by Type (2018-2023)
-
Table East China Peptides and Heparin Sales Volume by Application (2018-2023)
-
Table East China Peptides and Heparin Sales Volume Share by Application (2018-2023)
-
Figure East China Peptides and Heparin Sales Volume Share by Application (2018-2023)
-
Table Northeast China Peptides and Heparin Production Volume by Type (2018-2023)
-
Table Northeast China Peptides and Heparin Production Volume Share by Type (2018-2023)
-
Figure Northeast China Peptides and Heparin Production Volume Share by Type (2018-2023)
-
Table Northeast China Peptides and Heparin Sales Volume by Application (2018-2023)
-
Table Northeast China Peptides and Heparin Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Peptides and Heparin Sales Volume Share by Application (2018-2023)
-
Table Southwest China Peptides and Heparin Production Volume by Type (2018-2023)
-
Table Southwest China Peptides and Heparin Production Volume Share by Type (2018-2023)
-
Figure Southwest China Peptides and Heparin Production Volume Share by Type (2018-2023)
-
Table Southwest China Peptides and Heparin Sales Volume by Application (2018-2023)
-
Table Southwest China Peptides and Heparin Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Peptides and Heparin Sales Volume Share by Application (2018-2023)
-
Table Northwest China Peptides and Heparin Production Volume by Type (2018-2023)
-
Table Northwest China Peptides and Heparin Production Volume Share by Type (2018-2023)
-
Figure Northwest China Peptides and Heparin Production Volume Share by Type (2018-2023)
-
Table Northwest China Peptides and Heparin Sales Volume by Application (2018-2023)
-
Table Northwest China Peptides and Heparin Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Peptides and Heparin Sales Volume Share by Application (2018-2023)
-
Table Cipla Ltd Company Profile
-
Table Cipla Ltd Peptides and Heparin Revenue, Price and Gross (2018-2023)
-
Table United Biotech (P) Limited Company Profile
-
Table United Biotech (P) Limited Peptides and Heparin Revenue, Price and Gross (2018-2023)
-
Table Troikaa Pharmaceuticals Ltd Company Profile
-
Table Troikaa Pharmaceuticals Ltd Peptides and Heparin Revenue, Price and Gross (2018-2023)
-
Table Biological E Limited Company Profile
-
Table Biological E Limited Peptides and Heparin Revenue, Price and Gross (2018-2023)
-
Table VHB Life Sciences Limited Company Profile
-
Table VHB Life Sciences Limited Peptides and Heparin Revenue, Price and Gross (2018-2023)
-
Table Biocon Limited Company Profile
-
Table Biocon Limited Peptides and Heparin Revenue, Price and Gross (2018-2023)
-
Table Sun Pharmaceutical Industries Ltd Company Profile
-
Table Sun Pharmaceutical Industries Ltd Peptides and Heparin Revenue, Price and Gross (2018-2023)
-
Table Samarth Life Sciences Pvt Ltd Company Profile
-
Table Samarth Life Sciences Pvt Ltd Peptides and Heparin Revenue, Price and Gross (2018-2023)
-
Table Wockhardt Ltd Company Profile
-
Table Wockhardt Ltd Peptides and Heparin Revenue, Price and Gross (2018-2023)
-
Table Bharat Biotech Company Profile
-
Table Bharat Biotech Peptides and Heparin Revenue, Price and Gross (2018-2023)
-
Table Emcure Pharmaceuticals Pvt Ltd Company Profile
-
Table Emcure Pharmaceuticals Pvt Ltd Peptides and Heparin Revenue, Price and Gross (2018-2023)
-
